Matches in SemOpenAlex for { <https://semopenalex.org/work/W2149840424> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2149840424 endingPage "1800" @default.
- W2149840424 startingPage "1798" @default.
- W2149840424 abstract "Closeup4 November 2013Open Access The ‘captain of the men of death’, Streptococcus pneumoniae, fights oxidative stress outside the ‘city wall’ Alexandra Gennaris Alexandra Gennaris Welbio and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium Search for more papers by this author Jean-Francois Collet Corresponding Author Jean-Francois Collet Welbio and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium Search for more papers by this author Alexandra Gennaris Alexandra Gennaris Welbio and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium Search for more papers by this author Jean-Francois Collet Corresponding Author Jean-Francois Collet Welbio and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium Search for more papers by this author Author Information Alexandra Gennaris1 and Jean-Francois Collet 1 1Welbio and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium *Corresponding author: Tel: +32 2 764 7562; Fax: +32 2 764 7598;E-mail: [email protected] EMBO Mol Med (2013)5:1798-1800https://doi.org/10.1002/emmm.201303482 See related article in EMBO Molecular Medicine 10.1002/emmm.201202435 PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info We have come a long way since Streptococcus pneumoniae was first isolated in 1880. Over the years, the ability to combat this gram-positive bacterium branded ‘captain of the men of death’ by William Osler in 1918 has been greatly enhanced by the development of vaccines and antibiotics. However, despite the existence of these therapeutic strategies, S. pneumoniae continues to kill to this day. The bacterium, which is usually found as a resident of the human naso-oropharynx, causes indeed serious invasive diseases such as pneumonia, bacteraemia and meningitis, especially in young children, the elderly and immunocompromised individuals. Worldwide, it causes between 700,000 to 1 million child deaths every year (O'Brien et al, 2009). The limitations of existing vaccines, the emergence of antibiotic resistant clones, and the aging of the population will only make the problem worse, calling for new approaches against this pathogenic microorganism. S. pneumoniae is an anaerobic bacterium. However, it is tolerant to the oxygen (O2) present in the respiratory tract and is equipped with antioxidant systems to fight reactive oxygen species (ROS). ROS, such as superoxide () and hydrogen peroxide (H2O2), are produced by transfer of electrons to O2 following metabolic reactions or through the oxidative burst in neutrophils and macrophages. Like many other bacteria, S. pneumoniae possesses specialized antioxidant enzymatic squads that are in the front line to convert ROS to innocuous products unable to damage cellular components. The ROS detoxifying proteins that have been described in S. pneumoniae include a superoxide dismutase (SodA), a thiol peroxidase (TpxD) and an alkyl hydroperoxidase (AhpD). Interestingly, S. pneumoniae apparently lacks catalase, a ubiquitous H2O2 scavenger, and a response induced by oxidative stress (Yesilkaya et al, 2013). This is particularly intriguing given the fact that S. pneumoniae itself produces high amounts of H2O2, generated by the action of the pyruvate oxidase SpxB, to serve as a chemical weapon against the other bacteria present in the naso-oropharynx (Pericone et al, 2000). ROS molecules can damage cells in many ways (Imlay, 2013). In proteins, the sulfur-containing amino acids cysteine and methionine are very susceptible to oxidation, which can lead to protein inactivation or degradation. Thus, S. pneumoniae possesses widely conserved repair systems to cope with oxidative damage inflicted to proteins. Thioredoxin (Trx), a ubiquitous oxidoreductase, plays a major role in these systems either by directly repairing oxidized cysteines (Collet and Messens, 2010) or by providing reducing equivalents to enzymes, known as methionine sulfoxide reductases (Msr), which reduce oxidized methionines (Ezraty et al, 2005). One Trx (TrxA) and one Msr (SpMsrAB1) have been described in the cytoplasm of S. pneumoniae and partially characterized (Kim et al, 2009). Moreover, an additional Msr (SpMsrAB2), anchored to the cytoplasmic membrane, has recently been identified and shown to be part of a pneumococcal repair system called CTM (short for CcdA, TlpA, MsrAB). This system also involves CcdA1, which belongs to a family of bacterial proteins transferring electrons across membranes, and a thioredoxin-like lipoprotein, TlpA (Andisi et al, 2012). Although the CTM system was shown to be important for resistance towards H2O2 and for virulence, its function remained unclear. …Saleh et al (2013) add new pieces to the CTM puzzle and uncover a novel antioxidant artillery of S. pneumoniae. In this issue of EMBO Molecular Medicine, Saleh et al (2013) add new pieces to the CTM puzzle and uncover a novel antioxidant artillery of S. pneumoniae. The first step of the study was the finding that the S. pneumoniae chromosome encodes an additional CcdA protein (CcdA2) and a TlpA homolog (Etrx2). For clarity, TlpA was renamed Etxr1. They found that Etrx1, Etrx2 and SpMsrAB2 are exposed on the surface and that Etrx1 and Etrx2 are involved in two parallel pathways that provide reducing equivalents to SpMsrAB2. Their results also suggest that electrons are donated to Etrx1 and Etrx2 by the membrane proteins CcdA1 and CcdA2 (Fig 1). Thus, electrons likely originating from the cytoplasm cross the membrane via CcdA1 and CcdA2, are transferred to Etrx1 and Etrx2 and are finally provided to the methionine regenerating enzyme SpMsrAB2. Saleh et al went on to study the importance of the new reducing system in oxidative stress resistance and virulence using a set of mutants deleted for the various genes involved. They found that the absence of both pathways strikingly decreases the resistance of S. pneumoniae towards exogenously added H202. Moreover, mutants affected in both pathways have a dramatically reduced virulence in a mouse model of acute pneumonia and are significantly more phagocytosed by macrophages. Interestingly, impairment of either one of the Etrx1/Etrx2 pathways also has an impact, but clearly not to the extent observed when both pathways are affected. Thus, the authors bring to light a new extracellular reducing system composed of two complementary pathways that is essential for the virulence of S. pneumoniae and for its resistance to H2O2. Figure 1.Like many other bacteria, S. pneumoniae possesses reducing enzymes such as thioredoxin (TrxA) to rescue oxidized proteins TrxA is maintained reduced by thioredoxin reductase (TrxB) at the expense of NADPH. In S. pneumoniae, TrxA donates electrons to the membrane proteins CcdA1 and CcdA2. The electrons are then transferred to Etrx1/Etrx2 and finally to MsrAB2, a surface-exposed methionine sulfoxide reductase. See the main text for more details. Download figure Download PowerPoint Accumulating evidence has shown that scavenging and repair systems are of extreme importance for bacteria to cope with their environment and with the immune response. Moreover, repair enzymes such as Trx and Msr have been demonstrated to play a role in the virulence of pathogens such as Mycobacterium tuberculosis and Salmonella typhimurium (Bjur et al, 2006; Denkel et al, 2011; Lee et al, 2009). However, most of the reducing systems for which a clear role in virulence has been demonstrated are present in the bacterial cytoplasm. In contrast, although extra-cytoplasmic antioxidant pathways have been described (Cho and Collet, 2013), it remained unclear whether they play an important role in bacterial virulence. Thus, the findings of Saleh et al bring a novel element to the antioxidant bacterial force by showing that an extra-cytoplasmic reducing system is essential for the virulence of a pathogen. The paper also raises a number of interesting questions that require further investigation. For instance, one wonders if the Etrx proteins have other extracellular substrates than SpMsrAB2. Also of particular interest would be the identification of the substrates of SpMsrAB2 that need reduction of their oxidized methionines. Moreover, it would be judicious to further investigate the impact of extracytoplasmic reducing systems on the virulence of other major pathogens, these systems being the first line of defence towards the exogenous oxidative stress encountered during the immune response. Not only the conserved Etrx1/Etrx2 system is an attractive target for the development of new antimicrobials, but it could also be useful for the development of new vaccines. Finally, the study of Saleh et al provides a valuable contribution to the ongoing fight against S. pneumoniae. Not only the conserved Etrx1/Etrx2 system is an attractive target for the development of new antimicrobials, but it could also be useful for the development of new vaccines. Indeed, the existing vaccines, which are based on polysaccharide determinants of the pneumococcal capsule, cannot protect against all of the 90 capsular variants (serotypes) of the bacterium. Thus, targeting the surface-exposed Etrx1/Etrx2 system, which is common to all serotypes, could provide new means to claim victory over a dreaded human pathogen. The authors declare that they have no conflict of interest. References Andisi VF, Hinojosa CA, de Jong A, Kuipers OP, Orihuela CJ, Bijlsma JJ (2012) Pneumococcal gene complex involved in resistance to extracellular oxidative stress. Infect Immun 80: 1037-1049 CrossrefCASPubMedWeb of Science®Google Scholar Bjur E, Eriksson-Ygberg S, Aslund F, Rhen M (2006) Thioredoxin 1 promotes intracellular replication and virulence of Salmonella enterica serovar Typhimurium. Infect Immun 74: 5140-5151 CrossrefCASPubMedWeb of Science®Google Scholar Cho SH, Collet JF (2013) Many roles of the bacterial envelope reducing pathways. Antiox Redox Signal 18: 1690-1698 CrossrefCASPubMedWeb of Science®Google Scholar Collet JF, Messens J (2010) Structure, function, and mechanism of thioredoxin proteins. Antioxid Redox Signal 13: 1205-1216 CrossrefCASPubMedWeb of Science®Google Scholar Denkel LA, Horst SA, Rouf SF, Kitowski V, Böhm OM, Rhen M, Jäger T, Bange FC (2011) Methionine sulfoxide reductases are essential for virulence of Salmonella typhimurium. PLoS ONE 6: e26974 CrossrefCASPubMedWeb of Science®Google Scholar Ezraty B, Aussel L, Barras F (2005) Methionine sulfoxide reductases in prokaryotes. Biochim Biophys Acta 1703: 221-229 CrossrefCASPubMedWeb of Science®Google Scholar Imlay JA (2013) The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat Rev Microbiol 11: 443-454 CrossrefCASPubMedWeb of Science®Google Scholar Kim YK, Shin YJ, Lee WH, Kim HY, Hwang KY (2009) Structural and kinetic analysis of an MsrA-MsrB fusion protein from Streptococcus pneumoniae. Mol Microbiol 72: 699-709 Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Lee WL, Gold B, Darby C, Brot N, Jiang X, de Carvalho LP, Wellner D, St John G, Jacobs WR, Nathan C (2009) Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite. Mol Microbiol 71: 583-593 Wiley Online LibraryCASPubMedWeb of Science®Google Scholar O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, Hib and Pneumococcal Global Burden of Disease Study Team (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902 CrossrefPubMedWeb of Science®Google Scholar Pericone CD, Overweg K, Hermans PW, Weiser JN (2000) Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun 68: 3990-3997 CrossrefCASPubMedWeb of Science®Google Scholar Saleh M, Bartual SG, Abdullah MR, Jensch I, Asmat TM, Petruschka L, Pribyl T, Gellert M, Lillig CH, Antelmann H, et al (2013) Molecular architecture of Streptococcus pneumoniae surface thioredoxin-fold lipoproteins crucial for extracellular oxidative stress resistance and maintenance of virulence. EMBO Mol Med 5: 1852-1870 Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Yesilkaya H, Andisi VF, Andrew PW, Bijlsma JJ (2013) Streptococcus pneumoniae and reactive oxygen species: an unusual approach to living with radicals. Trends Microbiol 21: 187-195 CrossrefCASPubMedWeb of Science®Google Scholar Previous ArticleNext Article Volume 5Issue 121 December 2013In this issue FiguresReferencesRelatedDetailsLoading ..." @default.
- W2149840424 created "2016-06-24" @default.
- W2149840424 creator A5074733040 @default.
- W2149840424 creator A5084609492 @default.
- W2149840424 date "2013-11-04" @default.
- W2149840424 modified "2023-10-11" @default.
- W2149840424 title "The ‘captain of the men of death’, <i>Streptococcus pneumoniae</i> , fights oxidative stress outside the ‘city wall’" @default.
- W2149840424 cites W1981140994 @default.
- W2149840424 cites W2010050707 @default.
- W2149840424 cites W2021741522 @default.
- W2149840424 cites W2024642613 @default.
- W2149840424 cites W2049476905 @default.
- W2149840424 cites W2069480047 @default.
- W2149840424 cites W2094847059 @default.
- W2149840424 cites W2115635362 @default.
- W2149840424 cites W2121369371 @default.
- W2149840424 cites W2121533817 @default.
- W2149840424 cites W2125702226 @default.
- W2149840424 cites W2139951580 @default.
- W2149840424 cites W2142456941 @default.
- W2149840424 doi "https://doi.org/10.1002/emmm.201303482" @default.
- W2149840424 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3914527" @default.
- W2149840424 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24293314" @default.
- W2149840424 hasPublicationYear "2013" @default.
- W2149840424 type Work @default.
- W2149840424 sameAs 2149840424 @default.
- W2149840424 citedByCount "12" @default.
- W2149840424 countsByYear W21498404242016 @default.
- W2149840424 countsByYear W21498404242017 @default.
- W2149840424 countsByYear W21498404242018 @default.
- W2149840424 countsByYear W21498404242019 @default.
- W2149840424 countsByYear W21498404242020 @default.
- W2149840424 countsByYear W21498404242021 @default.
- W2149840424 countsByYear W21498404242022 @default.
- W2149840424 countsByYear W21498404242023 @default.
- W2149840424 crossrefType "journal-article" @default.
- W2149840424 hasAuthorship W2149840424A5074733040 @default.
- W2149840424 hasAuthorship W2149840424A5084609492 @default.
- W2149840424 hasBestOaLocation W21498404241 @default.
- W2149840424 hasConcept C126322002 @default.
- W2149840424 hasConcept C2776151105 @default.
- W2149840424 hasConcept C2781253189 @default.
- W2149840424 hasConcept C501593827 @default.
- W2149840424 hasConcept C71924100 @default.
- W2149840424 hasConcept C86803240 @default.
- W2149840424 hasConcept C89423630 @default.
- W2149840424 hasConceptScore W2149840424C126322002 @default.
- W2149840424 hasConceptScore W2149840424C2776151105 @default.
- W2149840424 hasConceptScore W2149840424C2781253189 @default.
- W2149840424 hasConceptScore W2149840424C501593827 @default.
- W2149840424 hasConceptScore W2149840424C71924100 @default.
- W2149840424 hasConceptScore W2149840424C86803240 @default.
- W2149840424 hasConceptScore W2149840424C89423630 @default.
- W2149840424 hasIssue "12" @default.
- W2149840424 hasLocation W21498404241 @default.
- W2149840424 hasLocation W21498404242 @default.
- W2149840424 hasLocation W21498404243 @default.
- W2149840424 hasLocation W21498404244 @default.
- W2149840424 hasOpenAccess W2149840424 @default.
- W2149840424 hasPrimaryLocation W21498404241 @default.
- W2149840424 hasRelatedWork W1976925323 @default.
- W2149840424 hasRelatedWork W2017369909 @default.
- W2149840424 hasRelatedWork W2026514246 @default.
- W2149840424 hasRelatedWork W2048846203 @default.
- W2149840424 hasRelatedWork W2134440230 @default.
- W2149840424 hasRelatedWork W2148349589 @default.
- W2149840424 hasRelatedWork W2382739716 @default.
- W2149840424 hasRelatedWork W2433393987 @default.
- W2149840424 hasRelatedWork W3035289353 @default.
- W2149840424 hasRelatedWork W4221125579 @default.
- W2149840424 hasVolume "5" @default.
- W2149840424 isParatext "false" @default.
- W2149840424 isRetracted "false" @default.
- W2149840424 magId "2149840424" @default.
- W2149840424 workType "article" @default.